Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
Cordier D, Reubi J, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer F, Merlo A. Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. Eur J Nucl Med Mol Imaging 2010; 37:1335-44.
16.02.2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
16.02.2010
Eur J Nucl Med Mol Imaging 2010; 37:1335-44
Cordier D, Reubi J C, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer Flavio, Merlo A
Weiter
